Stage II Breast Cancer Completed Phase 2 Trials for Letrozole (DB01006)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01194440Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal SymptomsSupportive Care
NCT00194779Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryTreatment
NCT00416715Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast CancerSupportive Care